Taby, Sweden

Ulf De Faire

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 2011-2019

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Ulf De Faire: Innovator in Cardiovascular Research

Introduction

Ulf De Faire is a notable inventor based in Taby, Sweden, recognized for his contributions to cardiovascular research. He has been instrumental in developing innovative methods and compositions aimed at understanding and preventing ischemic cardiovascular diseases. With a total of 2 patents, his work has significant implications for public health.

Latest Patents

Ulf De Faire's latest patents focus on phosphorylcholine conjugates and corresponding antibodies. One of his inventions proposes a method for determining antibodies, particularly IgM antibodies, toward phosphorylcholine. This method aims to identify subjects at risk of developing ischemic cardiovascular diseases. His research indicates that the presence of high levels of autoantibodies, especially IgM, is related to a decreased risk of developing such diseases. Additionally, he has explored pharmaceutical compositions that include phosphorylcholine conjugates or antibody preparations, which can be used as active or passive immunogens in the treatment or prevention of atherosclerosis.

Career Highlights

Ulf De Faire has made significant strides in the field of biotechnology, particularly through his work at Athera Biotechnologies AB. His research has contributed to a better understanding of the relationship between autoantibodies and cardiovascular health. His innovative approaches have opened new avenues for therapeutic interventions in atherosclerosis.

Collaborations

Throughout his career, Ulf has collaborated with esteemed colleagues such as Johan Frostegård and Nancy Pedersen. These partnerships have enhanced the depth and impact of his research, fostering advancements in the understanding of cardiovascular diseases.

Conclusion

Ulf De Faire's contributions to cardiovascular research through his patents and collaborations highlight his role as a leading innovator in the field. His work continues to influence the development of new therapeutic strategies for preventing ischemic cardiovascular diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…